These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38636711)

  • 1. Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin.
    Zukauskaite R; Kristensen MH; Eriksen JG; Johansen J; Samsøe E; Johnsen L; Lønkvist CK; Grau C; Hansen CR
    Radiother Oncol; 2024 Jul; 196():110284. PubMed ID: 38636711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins.
    Zukauskaite R; Hansen CR; Grau C; Samsøe E; Johansen J; Petersen JBB; Andersen E; Brink C; Overgaard J; Eriksen JG
    Radiother Oncol; 2018 Jan; 126(1):48-55. PubMed ID: 29248171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy.
    Hansen CR; Johansen J; Samsøe E; Andersen E; Petersen JBB; Jensen K; Andersen LJ; Sand HMB; Bertelsen AS; Grau C
    Radiother Oncol; 2018 Jan; 126(1):43-47. PubMed ID: 28987748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma.
    Due AK; Vogelius IR; Aznar MC; Bentzen SM; Berthelsen AK; Korreman SS; Kristensen CA; Specht L
    Strahlenther Onkol; 2012 Aug; 188(8):671-6. PubMed ID: 22580623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer.
    Caudell JJ; Meredith RF; Spencer SA; Keene KS; Dobelbower MC; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):164-8. PubMed ID: 19386438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of loco-regional failures in head and neck cancer after radical radiation therapy.
    De Felice F; Thomas C; Barrington S; Pathmanathan A; Lei M; Urbano TG
    Oral Oncol; 2015 Nov; 51(11):1051-1055. PubMed ID: 26506048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines.
    Grégoire V; Evans M; Le QT; Bourhis J; Budach V; Chen A; Eisbruch A; Feng M; Giralt J; Gupta T; Hamoir M; Helito JK; Hu C; Hunter K; Johansen J; Kaanders J; Laskar SG; Lee A; Maingon P; Mäkitie A; Micciche' F; Nicolai P; O'Sullivan B; Poitevin A; Porceddu S; Składowski K; Tribius S; Waldron J; Wee J; Yao M; Yom SS; Zimmermann F; Grau C
    Radiother Oncol; 2018 Jan; 126(1):3-24. PubMed ID: 29180076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
    Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods.
    Zukauskaite R; Hansen CR; Brink C; Johansen J; Asmussen JT; Grau C; Overgaard J; Eriksen JG
    Acta Oncol; 2017 Nov; 56(11):1554-1561. PubMed ID: 28826293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma.
    Chau RM; Teo PM; Choi PH; Cheung KY; Lee WY
    Radiother Oncol; 2001 Feb; 58(2):143-53. PubMed ID: 11166865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation.
    Lee N; Xia P; Fischbein NJ; Akazawa P; Akazawa C; Quivey JM
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):49-60. PubMed ID: 12909215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive functional image-guided IMRT in pharyngo-laryngeal squamous cell carcinoma: is the gain in dose distribution worth the effort?
    Castadot P; Geets X; Lee JA; Grégoire V
    Radiother Oncol; 2011 Dec; 101(3):343-50. PubMed ID: 21724283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer.
    Dawson LA; Anzai Y; Marsh L; Martel MK; Paulino A; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1117-26. PubMed ID: 10725621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
    Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
    Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.
    Geretschläger A; Bojaxhiu B; Dal Pra A; Leiser D; Schmücking M; Arnold A; Ghadjar P; Aebersold DM
    Radiat Oncol; 2015 Jan; 10():20. PubMed ID: 25595218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in patients with pharyngo-laryngeal cancer.
    Fondevilla Soler A; López-Guerra JL; García Fernández A; Samaniego Conde MA; Belmonte González MJ; Praena-Fernandez JM; Rivin Del Campo E; Alcaraz M; Azinovic I
    Clin Transl Oncol; 2019 Jul; 21(7):881-890. PubMed ID: 30506131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
    Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
    Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.
    Johansen S; Norman MH; Dale E; Amdal CD; Furre T; Malinen E; Evensen JF
    Radiat Oncol; 2017 May; 12(1):87. PubMed ID: 28545588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction.
    Al-Mamgani A; Kessels R; Janssen T; Navran A; van Beek S; Carbaat C; Schreuder WH; Sonke JJ; Marijnen CAM
    Radiother Oncol; 2022 Mar; 168():16-22. PubMed ID: 35065998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.